Groups Voice Support for Drug Shortages Bill; FDA Reports on Root Causes

The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists and Institute for Safe Medication Practices voiced strong support for the Mitigating Emergency Drug Shortages Act (S.2723), which includes provisions recommended by a recent drug shortages summit convened by the organizations. Introduced by Sens. Susan Collins, R-Maine, and Tina Smith, D-Minn., the legislation would require manufacturers to disclose the root causes and expected duration of shortages, and develop contingency plans to ensure an ongoing supply. It also would extend reporting requirements to include contract manufacturers and active pharmaceutical ingredients; develop recommendations to incentivize manufacturers to enter the market for drugs in shortage; and examine the national security risk of shortages.

Related Resources

Letter/Comment
Public
The Federation of American Hospitals and the American Hospital Association, urge Congress to oppose S. 2860 and any other legislation that would repeal current…
Letter/Comment
Public
AHA letter expressing support for the Maternal Health Quality Improvement Act (H.R.
Letter/Comment
Public
AHA letter expressing support for the Helping Medicaid Offer Maternity Services Act (H.R.
Letter/Comment
Public
AHA letter to the Congressional Telehealth Caucus in support of the CONNECT for Health Act of 2019.  
Letter/Comment
Public
AHA's comments to House leaders on the Lower Drug Costs Now Act (H.R. 3), legislation that would make a series of changes to the Medicare program in an effort…
Letter/Comment
Public
The AHA urges Senate appropriators to support federal funding for research and education to reduce violence in communities